Improved diagnosis and management of one of the most common cancers in men — prostate cancer — could result from research that has discovered that seminal fluid contains biomarkers for the disease. Results of a study have shown that the presence of certain molecules in seminal fluid indicates not only whether a man has prostate cancer, but also the severity of the cancer.